Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net loss	$ (24,045)	$ (20,713)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	587	595
Amortization	382
Loss on revaluation of contingent consideration	1,798
Non-cash lease expense	14	31
Stock-based compensation	10,262	10,623
Accretion and short-term investment discount		(287)
Changes in operating assets and liabilities:
Accounts receivable	691	1,268
Inventories	677	(550)
Prepaid expenses and other current assets	(146)	649
Other assets	29	71
Accounts payable	758	218
Accrued liabilities	(99)	(334)
Deferred revenue	574	(702)
Other liabilities	21	(8)
Net cash used in operating activities	(8,497)	(9,139)
Cash flows from investing activities
Purchase of property and equipment	(34)	(366)
Proceeds from maturity of short-term investments		20,131
Cash acquired in business acquisitions	108
Net cash provided by investing activities	74	19,765
Cash flows from financing activities
Proceeds from issuance of stock, net of issuance costs	297	81
Net cash provided by financing activities	297	81
Net (decrease) increase in cash, cash equivalents, and restricted cash	(8,126)	10,707
Cash, cash equivalents, and restricted cash at beginning of period	20,562	9,855
Cash, cash equivalents, and restricted cash at end of period	12,436	20,562
Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of December 31st:
Cash and cash equivalents	12,217	19,818
Restricted cash - current	219	525
Restricted cash		219
Total cash, cash equivalents, and restricted cash	$ 12,436	$ 20,562